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A vacuolar iron-transporter homologue acts as
a detoxiﬁer in Plasmodium
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Iron is an essential micronutrient but is also highly toxic. In yeast and plant cells, a key
detoxifying mechanism involves iron sequestration into intracellular storage compartments,
mediated by members of the vacuolar iron-transporter (VIT) family of proteins. Here we
study the VIT homologue from the malaria parasites Plasmodium falciparum (PfVIT) and
Plasmodium berghei (PbVIT). PfVIT-mediated iron transport in a yeast heterologous
expression system is saturable (KmB14.7mM), and selective for Fe2þ over other divalent
cations. PbVIT-deﬁcient P. berghei lines (Pbvit ) show a reduction in parasite load in both
liver and blood stages of infection in mice. Moreover, Pbvit parasites have higher levels of
labile iron in blood stages and are more sensitive to increased iron levels in liver stages, when
compared with wild-type parasites. Our data are consistent with Plasmodium VITs playing a
major role in iron detoxiﬁcation and, thus, normal development of malaria parasites in their
mammalian host.
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M
alaria imposes a massive global health burden, with a
current WHO estimate of around 600,000 deaths
annually1, although this ﬁgure could rise sharply if
treatment failures associated with artemisinin-combination
therapies becomes widespread. Perturbation of iron homeostasis
is an attractive strategy to target malaria parasites as Plasmodium,
like all cells, requires iron to survive2,3. Indeed, iron is an essential
micronutrient, necessary for fundamental cellular processes such
as ATP and DNA synthesis. While iron’s redox-active nature
makes it essential for many catalytic processes, it also underlies its
toxicity when present at high concentrations in the cytosol
or other sites. As such, all organisms have evolved a wide range
of strategies to acquire necessary iron and to detoxify any
excesses.
Iron enters cells through the activity of membrane transporters
or receptor-mediated endocytosis. While most of the intracellular
iron gets safely stored either in complex with the iron-storage
protein ferritin (for example, plant and mammalian cells) or
inside organelles (for example, yeast and plant cells), a small
amount of total cellular iron is present as a metabolically available
pool in the cytoplasm, termed the labile iron pool (LIP). The LIP
consists of iron loosely bound to small negatively charged
molecules and proteins4 and provides iron for cellular processes
including haem and Fe–S cluster biosyntheses5.
Appropriate storage of any excess of iron, which is not used
metabolically, is essential to prevent cellular toxicity due to
engagement of iron in Fenton-type chemistry in the presence of
oxygen and production of potentially damaging reactive oxygen
species6. Ferritin represents the most common and ancient
mechanism of iron storage and homeostasis in nature, as it is
found in most bacteria, archaea, plants and animals, but not in
yeast7. In the absence of ferritin, the yeast vacuole serves as the
main iron-storage/sequestration organelle. In response to
demands, iron moves to and from the yeast vacuole through
the activity of iron transporters in the yeast vacuolar membrane;
CCC1 (Ca2þ -sensitive cross complementer 1) is proposed to
import iron, while a complex constituted by Smf3p and
Fet5p-Fth1p exports iron8–10. Thus, vacuolar sequestration by
CCC1 in yeast is likely to be the primary mechanism for
detoxiﬁcation of excess iron in this organism. In addition to
ferritin found in plastids, plants also have several homologues of
CCC1, named vacuolar iron transporters (VITs), which are likely
to transport not only iron but also other divalent cations such as
manganese and zinc into the vacuole for storage and
detoxiﬁcation11–13.
Plasmodium parasites do not contain a homologue of ferritin
or any other known iron-storage protein14. However,
Plasmodium spp. genomes contain one orthologue of plant VIT
and yeast CCC1 proteins. Thus, we hypothesized that
mechanisms regulating intracellular iron storage in malaria
parasites may resemble those of yeast and plants. To test this
hypothesis, we assessed the ability of Plasmodium falciparum
VIT, PfVIT, to transport iron and sought to reveal the role of this
protein in the establishment and course of a malaria infection by
generating Plasmodium berghei parasites deﬁcient in VIT
(Pbvit ). We now show that Plasmodium VITs, expressed
throughout the parasite’s life cycle, transport iron and play a
major role in iron detoxiﬁcation in the parasite.
Results
Plasmodium genomes contain a VIT homologue. Bioinformatic
analysis shows that all Plasmodium spp. genomes encode
one gene with homology to yeast CCC1 and plant VIT proteins—
PF3D7_1223700 in P. falciparum and PBANKA_143860 in
P. berghei. PfVIT shares 28% amino-acid sequence identity with
Arabidopsis thaliana VIT, AtVIT1, and 19% with Saccharomyces
cerevisiae CCC1 (ClustalW2 multiple protein alignment). Like
VIT homologues in other organisms, both PfVIT and PbVIT are
predicted to have ﬁve transmembrane domains (Supplementary
Fig. 1). PfVIT has four phospho-acceptor sites at amino-acid
positions 21S, 122S, 140S and 150T, as reported previously15,16.
VITs are highly conserved across Plasmodium spp., with
open reading frames (ORF) split between two exons.
Orthologues in the species infecting humans (P. falciparum,
P. vivax and P. knowlesi) form a separate phylogenetic branch
from the orthologues of rodent malaria species (P. yoelii,
P. chabaudi and P. berghei; Fig. 1a). VIT homologues are
also present in other human pathogens of the Apicomplexa
phylum, such as Toxoplasma and Cryptosporidium. Furthermore,
kinetoplastid parasites Trypanosoma and Leishmania, causing
sleeping sickness and leishmaniasis, respectively, also encode
homologues of VIT proteins (Fig. 1a).
PfVIT complements a yeast strain lacking CCC1. S. cerevisiae
CCC1 most likely transports Fe2þ and Mn2þ into the vacuole,
based on the effect of CCC1 deletion and overexpression on
vacuolar accumulation of both of these ions8. Mutants lacking the
encoding gene for CCC1 (DCCC1) are susceptible to iron toxicity
in the presence of high extracellular iron concentrations but can
be rescued by expression of homologous plant VITs, such as
AtVIT1 (ref. 11), Tulipa gesneriana VIT1 (ref. 12) and Oryza
sativa VIT1 and VIT2 (ref. 13). To assess whether Plasmodium
VITs could rescue DCCC1 susceptibility to iron toxicity, a yeast
expression vector (pUGpd) containing codon-optimized
full-length pfvit (pfvit pUGpd; encoding 273 amino acids) and
50-truncated pfvit (spfvit-pUGpd; encoding 236 amino acids
and containing all 5 predicted transmembrane domains,
Supplementary Fig. 1) were transformed into S. cerevisiae
DCCC1. The latter was used because truncated transporters
in heterologous expression systems often demonstrate
increased activity, for example, because of autoinhibitory
effects17. Parallel transformation with empty vector (pUGpd)
and vector containing CCC1 (CCC1-pUGpd) were used as
negative and positive controls, respectively. Having conﬁrmed
that the appropriate sized gene sequences were present in
DCCC1::PfVIT, DCCC1::sPfVIT and DCCC1::pUGpd yeast
strains, western blot analysis of whole cell protein extract
demonstrated that full-length PfVIT heterologous protein
expression was very low compared with that of the truncated
version, with the latter being easily detectable in vacuolar
membrane fractions (Supplementary Fig. 1). Subsequently, yeast
growth assays on solid (qualitative) and in liquid (quantitative)
media were performed (Fig. 1b,c). The results show that very
low-level expression of PfVIT provided moderate but
signiﬁcant rescue of the DCCC1 phenotype at 2 and 3mM
Fe2þ (Po0.01, Student’s t-test; Fig. 1c). However, highly
expressed sPfVIT signiﬁcantly and strongly rescued the
DCCC1 phenotype at all tested Fe2þ concentrations (Po0.01;
Fig. 1c), although not to the degree measured in the
CCC1-expressing yeast positive control (which may be
the result of relatively low protein expression of heterologous
sPfVIT sequence compared with that of CCC1, or else it may
represent true differences in transport properties between
these two transporters, such as in substrate afﬁnity and
transporter capacity). Additionally, Zn2þ tolerance was also
tested by expression of sPfVIT in a Dzrc1 yeast strain, which is
sensitive to increased Zn2þ concentrations due to the lack of a
vacuolar Zn2þ importer18,19. Expression of sPfVIT did not
rescue Dzrc1 from sensitivity to high external Zn2þ
concentration (Supplementary Fig. 2).
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These data show that PfVIT, particularly when truncated, can
be expressed in S. cerevisiae and can complement the lack of
CCC1, implying that PfVIT acts as an iron transporter.
PfVIT mediates Fe2þ uptake. We next decided to test the ability
of sPfVIT to transport Fe2þ . We measured uptake of 55Fe2þ
into vacuolar vesicles isolated from transfected DCCC1::sPfVIT
yeast. 55Fe2þ uptake was over twofold higher in these vacuoles,
when compared with vector-only control vacuole preparations
(DCCC1::pUGpd) that were made at the same time, reaching 80%
of maximum uptake after 5min of incubation at 20 C (Fig. 2a).
The same fold increase in 55Fe2þ uptake was also observed
between paired sPfVIT and control vacuolar vesicles made on
different days, even though uptake relative to total protein levels
varied considerably (compare uptake presented in Fig. 2a with
that presented in Supplementary Fig. 3a). Using the same paired
vacuolar preparations used to generate the data presented in
Fig. 2a, linear-phase 55Fe2þ inﬂux in DCCC1::sPfVIT isolated
vacuoles measured over 1min was 4.2±0.3 pmolmin 1 mg 1
protein (mean±s.e.m.; n¼ 9), which was signiﬁcantly higher
than that measured in the same vacuoles placed on ice
(1.9±0.3 pmolmin 1 mg 1 protein; mean±s.e.m.; n¼ 9;
P¼ 0.0003; two-tailed, Student’s t-test) and in control vacuoles
(2.1±0.3 pmolmin 1 mg 1 protein; mean±s.e.m.; n¼ 8;
P¼ 0.0002; two-tailed, Student’s t-test). sPfVIT-mediated 55Fe2þ
inﬂux (deﬁned as the inﬂux in DCCC1::sPfVIT vacuoles minus
that measured in DCCC1::pUGpd vacuoles and normalized to
account for the variability noted above when averaging data
generated from more than one paired vacuolar preparation) was
inhibited by unlabelled Fe2þ in a concentration-dependent
manner (Fig. 2b) and was found to be pH-sensitive, with an
optimum between pH 6.5 and 7.5 (Fig. 2c). In competition assays
with divalent metals at 50-fold higher concentrations (that is, at
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Figure 1 | Iron tolerance of DCCC1 yeast conferred by the functional expression of PfVIT. (a) Phylogenetic analyses of Plasmodium VIT proteins
compared with other Apicomplexa and Kinetoplastida parasites and unrelated model organisms. The phylogenetic tree was generated using
Phylogeny.fr59 with yeast CCC1 sequence used as an out-group and visualized with TreeGraph 2 (ref. 60). The scale bar for the branch lengths is shown.
(b) Complementation of the DCCC1 yeast mutant growth phenotype by expression of PfVIT. The DCCC1 strain (lacking vacuolar iron uptake) was
transfected with empty vector pUGpd or vector expressing full-length PfVIT, N-terminally truncated PfVIT (sPfVIT) or CCC1. Transfected strains were
diluted (as indicated by OD600 values), spotted onto SD agar plates lacking histidine and supplemented with: no additional Fe
2þ , 3mM Fe2þ and 5mM
Fe2þ and grown at 30 C for 48 h. Fe2þ was provided as ammonium FeSO4 in the presence of 1mM ascorbic acid. (c) The DCCC1 transfectants described
in b were inoculated at a cell density of 0.01 OD600 in SD medium in the presence of indicated Fe
2þ concentrations (provided as ammonium FeSO4 in the
presence of 1mM ascorbic acid) and grown with shaking at 30 C for 20 h. Yeast cell density was determined by absorbance measurements at 600nm and
for each strain shown the OD600 values are normalized to those obtained in the absence of additional Fe
2þ in the medium (controls, 0mM Fe2þ ).
Data are shown as the means±s.e.m. of a pool of three independent experiments, each performed in triplicate. The data were analysed using the unpaired,
two-tailed Student’s t-test; **Po0.01, ***Po0.001.
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100mM), no other metal inhibited sPfVIT-mediated 55Fe2þ
uptake (Fig. 2d). This included Zn2þ , and thus is in agreement
with the Dzrc1 rescue assay described above. These data
demonstrate that PfVIT is selective for Fe2þ . Given the vacuolar
localization of the majority of VIT, they have been proposed to
act as Fe2þ /Hþ exchangers. Thus it is interesting that the
observed transport via sPfVIT occurred without the need to
acidify the yeast vacuoles by the addition of ATP, which activates
endogenous V-type Hþ pumps. To support this ﬁnding, we
further demonstrated that Fe2þ transport via sPfVIT was
insensitive to the V-type Hþ pump inhibitor baﬁlomycin A1 or
to the proton ionophore CCCP (Fig. 2d). Furthermore, to address
the possibility that the transport measurements via sPfVIT are an
artefact of Fe2þ vesicle surface binding, several additional
experiments were performed (Supplementary Fig. 3b). Adding the
divalent cation chelator EDTA to the wash solution used during
transport experiments (see Methods section) had no effect on
55Fe2þ uptake, while lysing vacuolar vesicle preparations by
either three freeze-thaw cycles before experimentation or addition
of the detergent Triton X-100 at the start of a 1-min transport
measurement signiﬁcantly reduced 55Fe2þ uptake. Finally, lysis
of vesicles using 0.1M HCl added directly following a 1-min
transport experiment signiﬁcantly reduced accumulated 55Fe2þ .
These results are consistent with 55Fe2þ accumulating within
vesicles rather than adsorbing/binding to vesicles.
PbVIT is expressed throughout the parasite’s life cycle.
Published transcriptomic data show that Pfvit is expressed in
P. falciparum blood-stage parasites with its abundance increasing
as the parasite progresses from early ring to mature trophozoite
stage20–22. We next generated a C-terminal green ﬂuorescent
protein (GFP) or myc fusion of PbVIT in P. berghei rodent
parasites, using a single crossover transfection strategy
(Supplementary Fig. 4). This allows the study of VIT expression
and localization throughout the parasite’s life cycle. Confocal
analysis after immunostaining with anti-GFP or anti-myc
antibodies showed PbVIT expression in asexual blood stages,
mosquito and liver stages of infection (Fig. 3 and Supplementary
Fig. 6). In blood-stage parasites, both tagged versions of PbVIT
mainly co-localized with PbBiP to the parasite’s endoplasmic
reticulum (Fig. 3a,b and Supplementary Fig. 5). We did not
observe PbVIT-GFP signal in regions around hemozoin crystals
in blood-stage parasites. In oocysts and liver-stage parasites
PbVIT-GFP also co-localized with PbBiP (Fig. 3c,d). Altogether,
these data strongly support the idea that PbVIT is expressed
mainly in the parasite ER throughout the parasite’s life cycle.
Pbvit parasites yield reduced liver and blood infections. Our
data have revealed a novel Plasmodium iron transporter whose
homologues in yeast and plants act as iron detoxiﬁers. We
therefore asked whether Plasmodium VITs play a similar role
during the parasite’s life cycle. To answer this question, we gen-
erated a P. berghei parasite line deﬁcient in the Pbvit gene
(Pbvit ), using a double crossover transfection strategy (Fig. 4a).
Pbvit parasites were cloned to obtain isogenic mutant lines,
which were used for all further analyses. Successful knockout of
pbvit demonstrates a non-essential role for this transporter during
asexual P. berghei blood stages. However, when controlled
experimental infections were performed, parasitemias in Pbvit
(two independent clones A2 and D1) infected mice were
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Figure 2 | Characterization of iron transport by PfVIT. 55Fe inﬂux was measured into vacuole-enriched vesicles isolated from DCCC1 yeast transfected
with empty or sPfVIT-expressing pUGpd vectors. (a) 55Fe uptake over time, measured at pH 7. (b) Inhibition of sPfVIT-mediated 55Fe2þ inﬂux (deﬁned as
the inﬂux in DCCC1::sPfVIT isolated vacuoles minus that measured in DCCC1::pUGpd vacuoles) by ‘cold’ unlabelled iron, measured over 1min at pH 7.
Shown is sPfVIT-mediated 55Fe2þ inﬂux in the presence of increasing concentrations of FeSO4 normalized to the condition without FeSO4, to allow
comparison between independent vacuolar preparations. (c) pH dependence of sPfVIT-mediated 55Fe2þ inﬂux, measured over 1min, normalized to that
obtained at pH7. (d) Inhibition of sPfVIT-mediated 55Fe2þ inﬂux by 100mM divalent metals, 1 mM baﬁlomycin A1 and 20mM CCCP, measured over 1min at
pH 7, normalized to uninhibited control sPfVIT-mediated 55Fe2þ inﬂux (**Po0.01; one-way analysis of variance, Dunnett’s Multiple Comparison Test). In
all panels, data are shown as means±s.e.m. of 6–8 inﬂux measurements performed at room temperature.
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signiﬁcantly reduced, when compared with those in mice infected
with wild-type (wt) parasites (Po0.05, Student’s t-test; Fig. 4b).
Furthermore, C57Bl/6 J mice infected with Pbvit parasites (104
infected RBC i.v.) survived signiﬁcantly longer compared with
mice infected with wt parasites (Po0.01, log-rank Mantel–Cox
test; Fig. 4c).
Notably, while Pbvit did not show any defect during
transmission to or development within Anopheles stephensi
mosquitoes (Supplementary Fig. 7), a signiﬁcant reduction in
parasite liver load was detected after Pbvit sporozoite infection.
Indeed, to investigate if Plasmodium VITs play a role during the
ﬁrst obligatory stage of Plasmodium infection in the mammalian
host, Pbvit or wt P. berghei sporozoites obtained from
A. stephensi mosquitoes were i.v. injected into C57Bl/6 J mice
and parasite liver load was measured 6 and 45h later. The data
show a moderate but signiﬁcant reduction in infection with Pbvit
(clone A2) sporozoites 6 h after injection (37±10% lower, when
compared with wt P. berghei infection; Po0.01, Student’s
t-test; Fig. 4d). Furthermore, 45h after infection the parasite liver
load was reduced by 64±19% for Pbvit clone A2 (Po0.01;
Fig. 4d) and by 53±19% for Pbvit clone D1 (Po0.05;
Supplementary Fig. 7), when compared with wt P. berghei
infection. Analysis of infected mouse liver sections, by microscopy,
show that the observed reduction in parasite liver load was due to a
lower number of infected hepatocytes (Fig. 4e), as well as moderate
reduction in size of developing Pbvit exoerythrocytic parasite
forms—EEFs (Fig. 4f). The combined effect of Pbvit deﬁciency
on both liver and blood stages was also observed following an
entire course of infection initiated with 500 Pbvit and wt
sporozoites (Supplementary Fig. 7).
Pbvit provides an iron detoxiﬁcation mechanism. In yeast and
plants, VIT proteins maintain the homeostasis of iron and some
other divalent metals by their sequestration from the cytoplasm
into organelles. Thus, to investigate the physiological role of
PbVIT and test our hypothesis that it detoxiﬁes excess iron by
sequestration, we compared the LIP in Pbvit and wt P. berghei
parasites. To that end, iRBCs containing either Pbvit or wt
parasites were stained with the iron-sensitive ﬂuorescent probe,
PhenGreen, and analysed by ﬂow cytometry (Supplementary
Fig. 8). The results show that the LIP of Pbvit iRBCs was sig-
niﬁcantly higher than that of wt P. berghei iRBCs (37±11%
increase; Po0.01, Student’s t-test; Fig. 5a).
Since the percentage of sporozoite-infected hepatoma cells
in vitro is extremely low, the PhenGreen ﬂow cytometry approach
is not appropriate to study the role of PbVIT during liver-stage
infection. We therefore employed an alternative strategy by
comparing sensitivities of Pbvit and wt liver-stage parasites to
iron depletion in vitro, by adding an iron chelator (deferoxamine,
DFO), and iron complementation, by adding Fe2þ (FeSO4 in the
presence of 1mM ascorbic acid). We determined the DFO EC50
for wt parasites developing in HepG2 cells to be 2.7 mM (95% CI
2.5–3 mM; Supplementary Fig. 9). Therefore, DFO concentrations
of 1, 2 and 3mM were used for further experiments comparing
Pbvit and wt parasites. For iron supplementation, concentra-
tions of up to 250 mM FeSO4 in the growth medium did not have
deleterious effects on the growth of wt parasites and HepG2 cell
viability (Supplementary Fig. 9) and, thus, concentrations of 100
and 200 mM FeSO4 were used in further experiments. While
under control conditions parasite liver load of Pbvit parasites
was not different from that of wt parasites (P¼ 0.16, one sample
t-test), Pbvit parasite load was lower compared with that of wt
parasites in conditions of excess iron (Fe2þ ; Fig. 5b), consistent
with a role for PbVIT in iron detoxiﬁcation. Conversely,
Pbvit parasites better tolerated chelation of iron by DFO
(Fig. 5c) and established higher parasites loads compared with wt
parasites in the presence of DFO in the growth medium. Taken
together, we show that Pbvit parasites harbour increased LIPs
and are more sensitive to environmental ﬂuctuations in iron
levels, leading to either growth defects under excess iron
conditions or growth rescue under iron chelating conditions.
Therefore, these data strongly support a key role for PbVIT in
cellular iron detoxiﬁcation in both blood and liver stages of
infection.
Discussion
Regulation of iron is essential for cell survival and should also,
therefore, be critical during the entire Plasmodium life cycle23–26.
Iron withdrawal by the use of iron chelators has been explored
as an antimalarial approach for decades27 and novel
compounds with improved pharmacokinetic properties are
being investigated23,24. During infection, growth of malaria
parasites is inﬂuenced by the host iron status both in liver25,28
and blood29. P. falciparum growth is reduced in iron-deﬁcient
erythrocytes while iron supplementation eliminates this
growth attenuation30. However, the inﬂuence of iron deﬁciency
and iron supplementation on malaria disease progression is
complex and remains a controversial topic because of conﬂicting
epidemiological and laboratory data31.
How malaria parasites import, export and store iron is not
currently understood in detail. Recently a P. berghei metal
transporter, ZIPCO, was described as important for the parasite’s
development in the liver26. While no direct transport studies were
performed to characterize the transport properties of ZIPCO; iron
and zinc supplementation and depletion experiments suggested it
plays a role in uptake of iron and zinc across the plasma
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Figure 3 | Expression of PbVIT in blood-, mosquito- and liver-stage
parasites. Indirect immunoﬂuorescence assay of PbVIT-GFP and PbVIT-
myc P. berghei. (a) Blood-stage PbVIT-GFP P. berghei (shown is a trophozoite
stage parasite). (b) Blood-stage PbVIT-myc P. berghei (shown is a
trophozoite stage parasite). (c) A mosquito midgut oocyst (17 days post
infection). (d) A liver-stage EEF, 48 h post infection of Huh7 the hepatoma
cell line with PbVIT-GFP sporozoites. Stainings were performed using
antibodies against GFP, myc (green) and PbBiP (ER marker, red), and
Hoechst nuclei stain (blue).
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membrane26. Mechanisms used by the parasite to store and
detoxify excess iron remain unknown. Asexual erythrocyte stage
parasites face high demands for maintaining iron homeostasis as
they digest iron-containing haemoglobin and the LIP increases
with their maturation from ring to schizont forms32. VIT family
members have been described in plants and yeast8,11–13,33,34
and, more recently, in the human pathogen Trypanosoma
brucei35 as important iron regulatory mechanisms. Our study is
the ﬁrst to characterize VIT homologues in Plasmodium and the
ﬁrst to conﬁrm the iron transport properties of any VIT
homologue.
We show here that expression of PfVIT restores transport of
Fe2þ into the vacuoles of yeast cells lacking CCC1—the yeast
VIT homologue, thereby rescuing the growth defective phenotype
of this strain in conditions of increased extracellular Fe2þ .
Interestingly, the rescue of the DCCC1 growth phenotype was far
greater when the N-terminal tail, before the ﬁrst predicted
transmembrane region, was removed (resulting in sPfVIT).
This is similar to the study of Ca2þ /Hþ exchangers
(CAXs), including the P. falciparum CAX, where the N-terminal
tail has autoinhibitory properties17,36. It is worth noting that
the N-terminus of PfVIT contains a phospho-acceptor site,
suggesting regulation by phosphorylation. However, our data
suggest that removal of the N-terminus improves greatly the
expression and subsequent delivery of sPfVIT to the yeast vacuole
and, thus, improving its function.
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Figure 4 | Pbvit knockout affects blood- and liver- stage growth of P. berghei. (a) Double crossover strategy for pbvit knockout and genotyping of the
Pbvit transgenic clonal line by PCR. Lane 1, detection of knockout construct integration at the 50 end (primers aþ b, 1.38 kb); lane 2, knockout construct
integration detection at the 30 end (primers cþ d, 1.23 kb); lane 3, wt pbvit locus (primers eþ d, 1.45 kb). (b) Parasitemia of C57Bl/6J mice following
infection (i.v.) with 104 wt P. berghei or Pbvit iRBCs, determined by counting of iRBC in Giemsa-stained blood smears (N¼ 10 for wt P. berghei-infected
mice and N¼ 5 for mice infected with Pbvit A2 or D1). (c) Survival of C57Bl/6 J mice infected i.v. with 104 wt or Pbvit iRBC (N¼ 20 for wt P. berghei-
infected mice and N¼ 10 for mice infected with Pbvit A2 or D1). Median survival was 7 and 9 days for wt and Pbvit , respectively, Po0.01, log-rank
Mantel–Cox test. (d) Parasite liver load 6 and 45 h after i.v. injection of wt or Pbvit sporozoites, assessed by reverse transcription PCR measurement of
parasite 18s RNA expression, normalized to mouse hypoxanthine-guanine phosphoribosyltransferase, shown are fold expressions relative to the average of
controls–wt P. berghei (shown is the pool of two independent experiments). (e) Number of EEFs per mm2 of livers 45 h after infection with 50,000 wt and
Pbvit sporozoites. Each point represents an average number of EEFs per mm2 per mouse liver by counting the number of EEFs in 5–8 slices per liver
(shown is a pool of two independent experiments, in total 795 wt EEFs and 210 Pbvit EEFs were counted). (f) Size of liver EEFs determined by measuring
the PbUIS4 surrounded area by ImageJ in confocal images of liver sections. The mean±s.e.m. size of wt and Pbvit EEFs was 728±25 (N¼ 58) and
629±23 (N¼46) mm2, respectively. In b,d,e and f error bars represent s.e.m. and the asterisks denote signiﬁcant differences using the two-tailed, unpaired
Student’s t-test: *Po0.05; **P o0.01 and ***Po0.001.
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While numerous VITs have been studied, the functional
characteristics of Fe2þ transport via VITs have yet to be
demonstrated. Here we have measured 55Fe2þ uptake into
isolated yeast vacuoles expressing sPfVIT (conﬁrmed by western
blot). sPfVIT-mediated 55Fe2þ uptake was consistent with
transport via a Fe2þ -speciﬁc carrier protein, with an
estimated Km value of approximately 15 mM, that was relatively
insensitive to pH between 6.5 and 7.5 (note the physiological
range of the parasite cytosol is pH 7.1–7.3 ref. 37). The Km value
would suggest that PfVIT is a relatively low afﬁnity/high capacity
transport pathway, given that LIP measurements in malaria
parasite iRBCs are 0.2–2mM (ref. 38). Most VITs have been
proposed to be Fe2þ /Hþ exchangers, given their localization and
proposed role (see below), with Fe2þ being accumulated into
acidic vacuoles. Yet our data were produced without the need to
acidify the yeast vacuoles by the addition of ATP, which activates
endogenous V-type Hþ -ATPases (and was unaffected by either a
speciﬁc inhibitor of this ATPase or a Hþ ionophore). Whether,
PfVIT is an exchanger or facilitative transporter and whether it is
a typical member of this family of transporters remains to be
established.
In plants and yeast, VITs are usually localized to the membrane
of their acidic vacuoles transporting excess iron from the
cytoplasm into the vacuole. Consistent with this, a T. brucei
VIT homologue has recently been shown to localize to
acidocalcisomes35. We initially hypothesized that Plasmodium
VIT would be expressed in the membrane of the parasite’s food
vacuole, where haemoglobin digestion and subsequent iron-
containing haem detoxiﬁcation occurs. However, while food
vacuoles are only observed in asexual blood stages of
development, analysis of published transcriptome and proteome
studies suggested expression of Plasmodium VITs throughout the
entire parasite’s life cycle15,39–41. Generation of a C-terminal GFP
or myc fusion of PbVIT in P. berghei allowed us to conﬁrm
complete life cycle expression. Additionally, colocalization studies
with selected parasite organelles’ markers imply PbVIT
localization in the parasite ER, in both liver and blood stages of
infection. While future studies are necessary to conﬁrm that
non-tagged versions of VIT are indeed in the ER, two plant
transporters with demonstrated functional homology to CCC1
have been shown to localize to the ER, more speciﬁcally to ER
bodies, where they act to maintain transition metal
homeostasis42. Thus, our study paves the way to explore further
the role of the ER in iron detoxiﬁcation.
As VIT and CCC1 homologues in plants and yeast,
respectively, are transporters that remove excess iron from the
cytoplasm and prevent iron toxicity, we therefore hypothesized
that Plasmodium VIT performs a similar function during the
parasite’s life cycle. Consistent with this, Pbvit parasites have
higher LIPs in blood stages and are more sensitive to increased
iron levels in liver stages, when compared with wt parasites. Most
importantly, Pbvit parasites show a reduction in parasite load
in both liver and blood stages of infection, also consistent with
Plasmodium VIT playing a major role in iron detoxiﬁcation and
highlighting the necessity for iron detoxiﬁcation if malaria
parasites are to remain viable in the mammalian host.
Notably, while our data show that PbVIT is important for both
liver and blood stages of infection, it is not essential during the
entire P. berghei life cycle. This may reﬂect a redundancy of
function with other compensatory mechanisms preventing iron
toxicity. In S. cerevisiae for example lack of vacuolar iron uptake by
CCC1 knockout is compensated by increased iron import into
mitochondria through MRS3 and MRS4 transporters43,44.
Additional protection mechanisms against high iron toxicity in
S. cerevisiae involve induction of iron–sulfur cluster-binding
proteins, such as TYW1 (ref. 45), an enzyme that participates in
the synthesis of wybutosine. Thus, in addition to sequestration of
iron into organelles, yeast cells avoid iron toxicity by consumption
of free cytosolic iron through the formation of protein-bound
iron–sulfur clusters. Plasmodium orthologues of mitochondrial
iron importers mrs3 and mrs4 remain to be identiﬁed, as does the
putative role of the Plasmodium orthologue of TYW1 and other
iron–sulfur cluster containing proteins in mediating protection
against high iron toxicity in malaria parasites.
In conclusion, our data provides new insights into how iron is
regulated within Plasmodium parasites. This knowledge is highly
relevant to better understand parasite biology and with regard to
malaria treatment and drug resistance. Artemisinins interact with
iron in vitro and iron chelators antagonize artemisinins in
these models46,47, although acute experiments in uncomplicated
malaria have not conﬁrmed antagonism in vivo48. However, the
effects of altered iron concentrations within the erythrocyte and
the parasite itself remain to be systematically studied with regard
to the efﬁcacy of artemisinin therapies. As such, of further interest
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Figure 5 | PbVIT functions in iron detoxiﬁcation by reducing the LIP. (a) The LIP of P. berghei wt and Pbvit iRBCs analysed by ﬂow cytometry. DMFI was
determined by evaluating the change in mean ﬂuorescence intensity of PhenGreen-loaded iRBCs (SYTO 61-positive subset), after incubation with
100mM DFO (DMFI¼MFIDFO treatedMFIDFO untreated). For each independent experiment, the MFI of Pbvit iRBCs was normalized to the mean MFI of
wt-iRBCs. Shown is a pool of four independent experiments (N¼ 14), **P¼0.0028 (unpaired, two-tailed Student’s t-test; wt mean±s.e.m.¼ 100±6,
Pbvit mean±s.e.m.¼ 137.1±10). (b) Liver-stage parasite load in HepG2 cells 45 h post infection with P. berghei wt and Pbvit sporozoites in the absence
or presence of FeSO4 and ascorbic acid in the growth medium, normalized to internal untreated control. Liver stage parasite load was determined by
reverse transcription PCR quantiﬁcation of parasite 18s expression normalized to human hypoxanthine-guanine phosphoribosyltransferase expression
(shown is a pool of ﬁve independent experiments). (c) Parasite load in HepG2 cells 45 h post infection in the absence or presence of DFO added to the
growth medium, determined as in b and normalized to internal untreated control (shown is a pool of ﬁve independent experiments). In b and c the asterisks
denote signiﬁcant differences using the two-tailed, unpaired Student’s t-test: *Po0.05.
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is to investigate altered drug sensitivity especially to quinolones or
artemisinins in parasites lacking VIT.
Methods
Yeast expression of PfVIT. The DCCC1 yeast strain and CCC1-expression
plasmid8 were kindly provided by Jerry Kaplan’s laboratory, University of Utah,
USA. A codon-optimised version of pfvit ORF (GenScript, USA Inc.) was used for
yeast expression (Supplementary Fig. 1). The expression plasmid was constructed
by subcloning the BamHI-XbaI codon-optimised pfvit fragment into the expression
vector pUGpd, containing the Ura selectable marker, yeast centromere sequence
and autonomously replicating sequence, which confers mitotic and meiotic
stability49. The N-truncated fragment of codon-optimized pfvit ORF was ampliﬁed
using primers sPfVITf and sPfVITr (Supplementary Table 1) and also subcloned
into the pUGpd vector. PfVIT and sPfVIT expressing pUGpd constructs as well as
CCC1-expression plasmid and empty pUGpd plasmid were transformed into the
DCCC1 yeast strain (lacking the VIT CCC1)8. sPfVIT-pUGpd and empty pUGpd
were also transformed into the Dzrc1 yeast strain (lacking a vacuolar zinc
transporter, ZRC1)18. Yeast strains were transformed using a previously described
Li–acetate method50 and selected on SD medium lacking uracil.
Preparation of vacuolar membrane vesicles from yeast. Yeast vacuolar
vesicles for 55Fe transport assays were isolated from DCCC1::PUG and
DCCC1::sPVIT-transfected strains according to a previously described protocol51,
with the following modiﬁcations: ultracentrifugation steps for initial pelleting of
microsomal membranes was at 120,000g, the subsequent sucrose gradient was at
150,000g and the ﬁnal pelleting of vacuoles was at 150,000g and were all performed
for 45min at 4 C. The ﬁnal vacuolar fraction was resuspended in 5mM Tris-MES,
pH 7.6, 0.3M sorbitol, 1mM dithiothreitol, 1mM PMSF and 1x protease inhibitor
(cOmplete, EDTA-free, Sigma-Aldrich) and frozen in liquid nitrogen until use.
Vacuolar preparations were always prepared as paired from DCCC1::PUG and
DCCC1::sPVIT on the same day, and paired preparations were used in the
transport experiments.
55Fe transport assays. For 55Fe uptake assays, vacuole vesicles at protein
concentration of 5–10 mg per reaction were prepared in reaction solution
containing 0.3M sorbitol, 5mM 3-(N-Morpholino)propanesulfonic acid (MOPS)
(pH 7), 25mM KCl, 1mM dithiothreitol, 0.2mM Na-azide and 1mM ascorbic
acid. Reactions were performed at pH 7, except for experiment to determine the
effect of pH. Uptakes were started by the addition of 55Fe at a ﬁnal concentration of
6 mCiml 1, corresponding to 2 mM Fe. Uptake reactions were performed at room
temperature (B20 C) and on ice. At the times indicated, aliquots (100 ml) of the
reaction mix were removed and ﬁltered through premoistened 0.45 mm pore-size
cellulose acetate GS type ﬁlters (Millipore) and washed three times with 1ml ice-
cold washing solution containing 0.3M sorbitol, 5mM Tris-MES (pH 7.5), 25mM
KCl, 100 mM FeSO4. For EDTA wash condition used to test the unspeciﬁc binding
of 55Fe, 100mM EDTA was added to the wash solution. The ﬁlters were air-dried
and radioactivity was determined by liquid scintillation counting. 55Fe inﬂux was
normalized to the protein content of the each vacuolar sample used in the
experiment.
Western blot analysis. Microsomal and vacuolar preps from DCCC1::pUGpd,
DCCC1::PVIT and DCCC1::sPVIT yeast were subjected to SDS–PAGE (7 mg of
protein was loaded for each) and electrotransferred to a nitrocellulose membrane.
For a loading control, membranes were stained with Ponceau S. After washing,
membranes were blocked in 5% skimmed milk and 0.1% Tween 20 in PBS for 3 h
at room temperature. Membranes were then probed with 1:500 diluted anti-PfVIT
antibody (afﬁnity puriﬁed peptide polyclonal goat antibody, antigen sequence
CGLIVTNEDKNE, from Genscript) overnight at 4 C and then incubated with
1:5,000 diluted HRP-conjugated secondary antibody. The signal was detected with
Luminata Crescendo Western HRP substrate (Millipore) and imaged with the
ChemiDoc XRSþ system.
Animal work. C57BL/6J and BALB/c wt mice were purchased from the Charles
River Breeding Laboratories and were housed in the facilities of the Instituto de
Medicina Molecular in Lisbon. All in vivo protocols were approved by the internal
animal care committee of the Instituto de Medicina Molecular and were performed
according to national and European regulations.
P. berghei transfection and culture. Transfection experiments were performed on
P. berghei ANKA strain 2.34 parasites according to a described protocol52. The
pbvit knockout vector was constructed for a double crossover homologous
recombination, as previously described53. Primer sequences used to amplify 50 and
30 untranslated regions are given in Supplementary Table 1. The ﬁnal knockout
construct was digested with KpnI and NotI to release the fragment for transfection.
The pyrimethamine-resistant parasite population containing the correct genomic
integration of the pbvit knockout construct was cloned by injecting one parasite per
mouse (BALB/c male mice, 6–8 weeks of age). To generate the pbvit-gfp
transfection construct (single crossover homologous recombination), a 0.8 kb
region of the pbvit was ampliﬁed without the stop codon and inserted in frame and
upstream of the gfp sequence in the transfection plasmid containing the human
dhfr cassette and conveying resistance to pyrimethamine. Similarly, Pbvit-myc
transfection construct was generated by inserting the same 0.8 kb region of the
pbvit in frame and upstream of the myc sequence in the transfection plasmid
containing the human dhfr cassette. Transfected P. berghei parasites were selected
with pyrimethamine selection pressure according to a described protocol52.
For liver-stage experiments, A. stephensi mosquitoes (produced by Instituto de
Medicina Molecular insectary) were fed on BALB/c male mice (6–8 weeks of age)
infected with wt, Pbvit and PbVIT-GFP P. berghei. For collection of salivary
gland sporozoites, infected mosquitoes were dissected on the 21st day post
infection.
Genotype analysis of P. berghei transfectants. PCR analysis performed on
genomic DNA isolated from transgenic P. berghei was used to inspect if the
transfection constructs integrated into the correct loci in pyrimethamine-resistant
parasites. Sequences of primers used for genotyping are provided in Supplementary
Table 1.
Culturing and infection of hepatoma cells. HepG2 and Huh7 hepatoma cells
(ATCC, USA) were cultured in supplemented Dulbecco’s modiﬁed Eagle’s medium
or RPMI 1640, respectively, and maintained in a 5% CO2 humidiﬁed incubator at
37 C. For determination of the parasite infection load in vitro, 50,000 HepG2 cells
were plated per well of a 24-well culture plate and 24 h later infected with 30,000 wt
or Pbvit sporozoites per well. Post infection, hepatoma cells were cultured in
the presence of 0.3% Fungizone (added to the culture medium). After 45 h of
incubation under standard culture conditions in the presence or absence of DFO
(1–3 mM) or FeSO4 (100–200 mM) added to the culture medium, infected cells
were collected for RNA extraction and parasite load was analysed by Real-time
PCR (Supplementary Table 1).
Analysis of the PbVIT-GFP localization. BALB/c male mice (6–8 weeks of age)
infected with PbVIT-GFP P. berghei were bled and the suspension of infected blood
in RPMI medium was passed through a CF-11 cellulose column to remove
leukocytes. After three washes in PBS, blood stages of PbVIT-GFP P. berghei were
immunostained according to a previously described protocol54. For liver-stage
localization experiments, HepG2 or Huh7 hepatoma cells were seeded on imaging
coverslips in a 24-well culture plate and infected with PbVIT-GFP P. berghei
sporozoites. Coverslips were ﬁxed at indicated time points post infection in 4%
paraformaldehyde/PBS solution for 15min at room temperature. After three
washes in PBS, coverslips were incubated for 45min in a permeabilization/blocking
solution containing 0.1% Triton X-100 and 2% bovine serum albumin in PBS.
Coverslips were then incubated for a minimum of 2 h at room temperature in the
primary antibody solution diluted accordingly in the permeabilization/blocking
solution. Following three washes in PBS, coverslips were then stained with a
mixture of appropriate secondary antibodies, diluted 1:500 in the permeabilization/
blocking solution. All stainings for indirect immunoﬂuorescence assay (IFA)
presented in Fig. 3 were performed using a monoclonal mouse anti-GFP antibody
(Abcam; 1:500). Additional, control stainings presented in Supplementary Fig. 4
were performed using a rabbit polyclonal anti-GFP antibody (Abcam; 1:500). For
colocalization experiments, rabbit anti-PbBiP was used at a 1:600 dilution and goat
anti-PbUIS4 diluted 1:1,000. The secondary antibodies used were: donkey anti-
mouse conjugated to Alexa Fluor 488, donkey anti-rabbit conjugated to Alexa
Fluor 549 and donkey anti-goat conjugated to Alexa Fluor 660. All images of
PbVIT-GFP-expressing parasites were captured with a Zeiss LSM 710 confocal
point-scanning microscope. Hoechst 33342 was used for nuclear staining.
The PbBiP antibody (rabbit, polyclonal) was designed to recognize a highly
conserved C-terminal region of PBANKA_081890 (GANTPPPGDEDVDS) based
on previously widely used P. falciparum BiP antibody55, which also cross-reacted
with P. berghei56.
Immunohistochemical staining of liver sections. Livers isolated from infected
mice were ﬁxed with 4% paraformaldehyde at room temperature for 2 h. The ﬁxed
liver lobes were cut into 50-mm-thick sections using the Vibratome VT 1000S
(Leica). Following blocking in 2% bovine serum albumin and 0.3% Triton X-100 at
4 C overnight, liver sections were stained with goat anti-P. berghei UIS4 (1:1,000)
(ref. 57) and mouse anti-P. berghei HSP70 (1:1,000) (ref. 58). The secondary
antibodies used for detection were: Alexa Fluor 555 donkey anti-goat antibody and
donkey anti-mouse conjugated to Alexa Fluor 488 (all 1:500). Cell nuclei were
stained with diamidino-2-phenylindole. Stained liver sections were mounted on
microscope slides with Fluoromount-G (SouthernBiotech). Images were acquired
on a LSM 710 confocal point-scanning microscope (Zeiss).
Determination of the LIP of iRBCs. The LIP of RBCs infected with wt and Pbvit
parasites was determined by ﬂow cytometry using the PhenGreen ﬂuorescent iron
probe. The staining protocol before ﬂow cytometry measurement was based on a
recently published method for P. falciparum32 with the following modiﬁcation:
infected BALB/c male mice (6–8 weeks of age) with 1.5–2.8% parasitemia were bled
and the RBCs incubated in culture overnight to enrich the culture for mature
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parasite stages. RBCs were washed in PBS and stained with PhenGreen for 45min
(10 mM probe in serum-free RPMI 1640 medium). Following two washes in PBS,
cells were incubated for 1 h in standard culture conditions with 0.5 mM Syto61
DNA stain, in the presence or absence of 100 mM DFO or 100 mM FeSO4þ 1mM
ascorbic acid. After washing, stained cells were analysed on a FACSCalibur. The
geometric mean of PhenGreen ﬂuorescence for the FL1-H, FL4-H subset
(Supplementary Fig. 7) was determined for all samples. The amount of labile iron
was estimated for each sample as that relative to the DFO condition (DMFI).
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